Inhibition of virus replication by RNA interference

Journal of Biomedical Science

Volumn 10, Issue 6, 2003, Pages 607-616

  Haasnoot, P C Joost ^a   Cupac, Daniel ^a   Berkhout, Ben ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Replication; RNA interference; siRNA; Virus

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA; SMALL INTERFERING RNA; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DOUBLE STRANDED RNA; GAG PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEF PROTEIN; POL PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANTIVIRAL ACTIVITY; BIOTECHNOLOGY; CELL TYPE; DRUG EFFICACY; DRUG TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOXICITY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; RNA INTERFERENCE; VIRUS GENE; BACULOVIRUS; DENGUE VIRUS; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES VIRUS; INFLUENZA VIRUS A; LONG TERMINAL REPEAT; POLIOMYELITIS VIRUS; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN MOTIF; REVERSE TRANSCRIPTION; RNA GENE; ROUS SARCOMA ONCOVIRUS; SEMLIKI FOREST ALPHAVIRUS; T LYMPHOCYTE; VIRUS NUCLEOCAPSID; WART VIRUS;

DENGUE VIRUS; EUKARYOTA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; POLIOVIRUS; TRANSPOSONS;

ANIMALS; GENE THERAPY; GENES, VIRAL; HIV-1; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRUS REPLICATION;

EID: 0242331187     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000073526     Document Type: Review

References (72)

1. Adelman ZN, Blair CD, Carlson JO, Beaty BJ, Olson KE. Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol Biol 10:265-273;2001.
2. Adelman ZN, Sanchez-Vargas I, Travanty EA, Carlson JO, Beaty BJ, Blair CD, Olson KE. RNA silencing of dengue virus type 2 replication in transformed C6/36 mosquito cells transcribing an inverted-repeat RNA derived from the virus genome. J Virol 76:12925-12933;2002.
3. Barton GM, Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci USA 99:14943-14945;2002.
4. Baulcombe D. Viral suppression of systemic silencing. Trends Microbiol 10:306-308;2002.
5. Bradley DW. Hepatitis viruses: their role in human cancer. Proc Assoc Am Physicians 111:588-593;1999.
6. Brigneti G, Voinnet O, Li WX, Ji LH, Ding SW, Baulcombe DC. Viral pathogenicity deter minants are suppressors of transgene silencing in Nicotiana benthamiana. EMBO J 17:6739-6746;1998.
7. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553;2002.
8. Brummelkamp TR, Das AT, Vink M, Madi redjo M, Bernards R, Berkhout B. HIV-1 escapes from RNA interference mediated inhibition, submitted.
9. Caplen NJ, Zheng Z, Falgout B, Morgan RA. Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference. Mol Ther 6:243-251;2002.
10. Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 169:5196-5201;2002.
11. Chi JT, Chang HY, Wang NN, Chang DS, Dunphy N, Brown PO. Genome-wide view of gene silencing by small interfering RNAs. Proc Natl Acad Sci USA 100:6343-6346;2003.
12. Coburn GA, Cullen BR. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 76:9225-9231;2002.
13. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J. Genomic structure of an attenuated quasi species of HIV-1 from blood transfusion donor and recipients. Science 270:988-991;1995.
14. Dector MA, Romero P, Lopez S, Arias CF. Rotavirus gene silencing by small interfering RNAs. EMBO Rep 3:1175-1180;2002.
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498;2001.
16. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15:188-200;2001.
17. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811;1998.
18. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408:325-330;2000.
19. Gaines PJ, Olson KE, Higgs S, Powers AM, Beaty BJ, Blair CD. Pathogen-derived resistance to dengue type 2 virus in mosquito cells by expression of the premembrane coding region of the viral genome. J Virol 70:2132-2137;1996.
20. Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 100:2718-2723;2003.
21. Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418:430-434;2002.
22. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2:33-42;2002.
23. Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 543:51-54;2003.
24. Hannon GJ. RNA interference. Nature 418:244-251;2002.
25. Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 30:1757-1766;2002.
26. Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD. Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 12:1301-1311;2002.
27. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635-637;2003.
28. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 418:435-438;2002.
29. Jia Q, Sun R. Inhibition of gammaherpesvirus replication by RNA interference. J Virol 77:3301-3306;2003.
30. Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21:6041-6048;2002.
31. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, Welchman DP, Zipperlen P, Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421:231-237;2003.
32. Kapadia SB, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA 100:2014-2018;2003.
33. Ketting RF, Haverkamp TH, van Luenen HG, Plasterk RH. Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell 99:133-141;1999.
34. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20:500-505;2002.
35. Li H, Li WX, Ding SW. Induction and suppression of RNA silencing by an animal virus. Science 296:1319-1321;2002.
36. Li WX, Ding SW. Viral suppressors of RNA silencing. Curr Opin Biotechnol 12:150-154;2001.
37. Lindbo JA, Dougherty WG. Untranslatable transcripts of the tobacco etch virus coat protein gene sequence can interfere with tobacco etch virus replication in transgenic plants and protoplasts. Virology 189:725-733;1992.
38. Lipardi C, Wei Q, Paterson BM. RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell 107:297-307;2001.
39. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377;1996.
40. Martinez MA, Gutierrez A, Armand-Ugon M, Blanco J, Parera M, Gomez J, Clotet B, Este JA. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 16:2385-2390;2002.
41. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Wieland SF, Marion PL, Kay MA. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol. 21:639-644;2003.
42. Means JC, Muro I, Clem RJ. Silencing of the baculovirus Op-iap3 gene by RNA interference reveals that it is required for prevention of apoptosis during Orgyia pseudotsugata M nucleopolyhedrovirus infection of Ld652Y cells. J Virol 77:4481-4488;2003.
43. Napoli C, Lemieux C, Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2:279-289;1990.
44. Neumann G, Whitt MA, Kawaoka Y. A decade after the generation of a negative-sense RNA virus from cloned c. J Gen Virol 83:2635-2662;2002.
45. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P, Sharp PA. siRNA-directed inhibition of HIV-1 infection. Nat Med 8:681-686;2002.
46. Park WS, Miyano-Kurosaki N, Hayafune M, Nakajima E, Matsuzaki T, Shimada F, Takaku H. Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res 30:4830-4835;2002.
47. Pomar N, Berlanga JJ, Campuzano S, Hernandez G, Elias M, de Haro C. Functional characterization of Drosophila melanogaster PERK eukaryotic initiation factor 2alpha (eIF2alpha) kinase. Eur J Biochem 270:293-306;2003.
48. Qin XF, An DS, Chen IS, Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 100:183-188;2003.
49. Randall G, Grakoui A, Rice CM. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci USA 100:235-240;2003.
50. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242:55-84;2000.
51. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber C-M, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725;1996.
52. Semizarov D, Frost L, Sarthy A, Kroeger P, Halbert DN, Fesik SW. Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA 100:6347-6352;2003.
53. Seo MY, Abrignani S, Houghton M, Han JH. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J Virol 77:810-812;2003.
54. Sharp PA. RNA interference-2001. Genes Dev 15:485-490;2001.
55. Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37:764-770;2003.
56. Sijen T, Fleenor J, Simmer F, Thijssen KL, Parrish S, Timmons L, Plasterk RH, Fire A. On the role of RNA amplification in dsRNA-triggered gene silencing. Cell 107:465-476;2001.
57. Smith NA, Singh SP, Wang MB, Stoutjesdijk PA, Green AG, Waterhouse PM. Total silencing by intron-spliced hairpin RNAs. Nature 407:319-320;2000.
58. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9:347-351;2003.
59. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501;2003.
60. Surabhi RM, Gaynor RB. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J Virol 76:12963-12973;2002.
61. Szweykowska-Kulinska Z, Jarmolowski A, Figlerowicz M. RNA interference and its role in the regulation of eucaryotic gene expression. Acta Biochim Pol 50:217-229;2003.
62. Tijsterman M, Ketting RF, Plasterk RH. The genetics of RNA silencing. Annu Rev Genet 36:489-519;2002.
63. Valdes VJ, Sampieri A, Sepulveda J, Vaca L. Using double-stranded RNA to prevent in vitro and in vivo viral infections by recombinant baculovirus. J Biol Chem 278:19317-19324;2003.
64. Vance V, Vaucheret H. RNA silencing in plants - defense and counterdefense. Science 292:2277-2280;2001.
65. Voinnet O. RNA silencing: small RNAs as ubiquitous regulators of gene expression. Curr Opin Plant Biol 5:444-451;2002.
66. Voinnet O, Pinto YM, Baulcombe DC. Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses of plants. Proc Natl Acad Sci USA 96:14147-14152;1999.
67. Wang MB, Waterhouse PM. Application of gene silencing in plants. Curr Opin Plant Biol 5:146-150;2002.
68. Waterhouse PM, Graham MW, Wang MB. Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA Proc Natl Acad Sci USA 95:13959-13964;1998.
69. Waterhouse PM, Smith NA, Wang MB. Virus resistance and gene silencing: Killing the messenger. Trends Plant Sci 4:452-457;1999.
70. Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervais IG, Arya S, Sarangi F, Harris-Brandts M, Beaulieu S, Richardson CD. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA 100:2783-2788;2003.
71. Yamamoto T, Omoto S, Mizuguchi M, Mizukami H, Okuyama H, Okada N, Saksena NK, Brisibe EA, Otake K, Fuji YR. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol Immunol 46:809-817;2002.
72. Yokota T, Sakamoto N, Enomoto N, Tanabe Y, Miyagishi M, Maekawa S, Yi L, Kurosaki M, Taira K, Watanabe M, Mizusawa H. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 4:1-7;2003.